Lee Elizabeth Wachtel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lee Elizabeth Wachtel has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Dirk M. Dhossche
6 shared publicationsIrving M. Reti
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland
4 shared publications- Charles H. Kellner
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC
2 shared publications Dirk Marcel Dhossche
From the *Kennedy Krieger Institute, Johns Hopkins School of Medicine, Baltimore, MD and †University of Mississippi School of Medicine
2 shared publicationsIrving Michael Reti
Johns Hopkins School of Medicine, USA
2 shared publicationsMerrie Griffin
2 shared publications
Latest Publications
- 7 August 2025
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 152 (5) , 325-327
How to Quickly Diagnose Catatonia, and a Farewell Salute to Max Fink, MD
- 7 August 2025
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 152 (5) , 325-327
How to Quickly Diagnose Catatonia, and a Farewell Salute to Max Fink, MD
- 2 June 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 42 (2) , 71-72
Dire Need and Disproportionate Access
- 2 June 2025
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 42 (2) , 71-72
Dire Need and Disproportionate Access
- 20 December 2024
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 38 (2) , 79-86
Electroconvulsive therapy in autism spectrum disorders: an update to the literature
Purpose of review: Over the last quarter century, the clinical evidence surrounding the use of electroconvulsive therapy (ECT) in individuals with autism spectrum disorder (ASD) has expanded. This review provides the most up-to-date findings on the usage of ECT in ASD and discusses these results within the historical context and direct patient care experience. Recent findings: ECT is typically implemented for psychotropic-refractory catatonic, affective, psychotic, and combined pathology for individuals across the lifespan. Although highly stigmatized, ECT is well tolerated, efficacious, and potentially lifesaving for select individuals. A case presentation of an individual with autism as well as a summary of legal restrictions hampering his ECT access is presented. Summary: ECT is increasingly used in individuals with ASD who present with a wide range of ECT-responsive psychopathology, as well as repetitive self-injury and late, autistic-like regression for which no cause is found. ECT is well tolerated and offers real hope for many ASD individuals with devastating, treatment-refractory conditions.
- 20 December 2024
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 38 (2) , 79-86
Electroconvulsive therapy in autism spectrum disorders: an update to the literature
Purpose of review: Over the last quarter century, the clinical evidence surrounding the use of electroconvulsive therapy (ECT) in individuals with autism spectrum disorder (ASD) has expanded. This review provides the most up-to-date findings on the usage of ECT in ASD and discusses these results within the historical context and direct patient care experience. Recent findings: ECT is typically implemented for psychotropic-refractory catatonic, affective, psychotic, and combined pathology for individuals across the lifespan. Although highly stigmatized, ECT is well tolerated, efficacious, and potentially lifesaving for select individuals. A case presentation of an individual with autism as well as a summary of legal restrictions hampering his ECT access is presented. Summary: ECT is increasingly used in individuals with ASD who present with a wide range of ECT-responsive psychopathology, as well as repetitive self-injury and late, autistic-like regression for which no cause is found. ECT is well tolerated and offers real hope for many ASD individuals with devastating, treatment-refractory conditions.
- 23 January 2024
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 71 (2) , 301-313
Profound Autism
- 23 January 2024
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 71 (2) , 301-313
Profound Autism
- Open Access
- 16 November 2021
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 45 (1) , 123-131
The Impact of COVID-19 on Brain Stimulation Therapy
- 16 November 2021
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 45 (1) , 123-131
Open AccessThe Impact of COVID-19 on Brain Stimulation Therapy
- 20 August 2020
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 37 (1) , 10-12
Far From an Elective Procedure
- 20 August 2020
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 37 (1) , 10-12
Far From an Elective Procedure
- 1 October 2019
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 58 (10) , S66
46.2 CATATONIA IN ASD
- 1 October 2019
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 58 (10) , S66
46.2 CATATONIA IN ASD
- 2 December 2018
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 139 (1) , 46-55
Treatment of catatonia in autism spectrum disorders
Objective: To review the treatment courses of 22 autistic patients diagnosed with catatonia over a 12‐year period, including treatment with benzodiazepines and electroconvulsive therapy.Method: Retrospective review of inpatient and outpatient records of 22 autistic youth presenting to a neurobehavioral service who were treated for catatonia.Results: Six girls and 16 boys ranging from ages 8 to 26 years old presenting for neurobehavioral assessment were found to meet criteria for catatonia according to the DSM5 and were treated for such. All but one patient was initially unsuccessfully treated with benzodiazepines in dosages ranging from 1 to 27 mg daily, and all patients underwent electroconvulsive therapy. Mean age of ECT start was 15.6 years old, and the total number of ECT received ranged from 16 to 688, with 13 patients still receiving maintenance ECT at the end of the study period. ECT conferred prominent patient benefit in terms of catatonic symptom reduction, including alleviation of incapacitating, treatment‐resistant self‐injury.Conclusion: Myriad symptoms of catatonia were seen in this sample of 22 autistic youth. Implementation of anti‐catatonic paradigms, particularly electroconvulsive therapy, conferred vast patient benefit.
- 2 December 2018
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 139 (1) , 46-55
Treatment of catatonia in autism spectrum disorders
Objective: To review the treatment courses of 22 autistic patients diagnosed with catatonia over a 12‐year period, including treatment with benzodiazepines and electroconvulsive therapy.Method: Retrospective review of inpatient and outpatient records of 22 autistic youth presenting to a neurobehavioral service who were treated for catatonia.Results: Six girls and 16 boys ranging from ages 8 to 26 years old presenting for neurobehavioral assessment were found to meet criteria for catatonia according to the DSM5 and were treated for such. All but one patient was initially unsuccessfully treated with benzodiazepines in dosages ranging from 1 to 27 mg daily, and all patients underwent electroconvulsive therapy. Mean age of ECT start was 15.6 years old, and the total number of ECT received ranged from 16 to 688, with 13 patients still receiving maintenance ECT at the end of the study period. ECT conferred prominent patient benefit in terms of catatonic symptom reduction, including alleviation of incapacitating, treatment‐resistant self‐injury.Conclusion: Myriad symptoms of catatonia were seen in this sample of 22 autistic youth. Implementation of anti‐catatonic paradigms, particularly electroconvulsive therapy, conferred vast patient benefit.
- 1 August 2018
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 28 (4) , 471-480
The multiple faces of catatonia in autism spectrum disorders: descriptive clinical experience of 22 patients over 12 years
A retrospective review was conducted from the inpatient and outpatient records of twenty-two autistic youth presenting to a neurobehavioral service over a twelve-year period for combined psychiatric and behavioral pathology who also met DSM5 criteria for catatonia. Six autistic girls and 16 autistic boys ranging from ages eight to 26 years old were identified, and their variegated symptoms evaluated. Stereotypy, posturing, negativism, mutism and stupor were the most common catatonic symptoms, each present in more than half of the study patients. One patient had abnormal vital signs indicative of malignant catatonia. Twenty patients had concomitant repetitive self-injurious behaviors that had led to significant tissue injury and were refractory to psychotropic and behavioral interventions. The sample was weighted towards patients with severe self-injurious behavior, which often was the reason for admission. The many “faces” of catatonia in autism spectrum disorders are seen in this sample, and the novel recognition of repetitive self-injury as an under-recognized motor symptom of catatonia is highlighted. The preliminary findings in this study open many important future vistas for ongoing research regarding catatonia in ASDs.
- 1 August 2018
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 28 (4) , 471-480
The multiple faces of catatonia in autism spectrum disorders: descriptive clinical experience of 22 patients over 12 years
A retrospective review was conducted from the inpatient and outpatient records of twenty-two autistic youth presenting to a neurobehavioral service over a twelve-year period for combined psychiatric and behavioral pathology who also met DSM5 criteria for catatonia. Six autistic girls and 16 autistic boys ranging from ages eight to 26 years old were identified, and their variegated symptoms evaluated. Stereotypy, posturing, negativism, mutism and stupor were the most common catatonic symptoms, each present in more than half of the study patients. One patient had abnormal vital signs indicative of malignant catatonia. Twenty patients had concomitant repetitive self-injurious behaviors that had led to significant tissue injury and were refractory to psychotropic and behavioral interventions. The sample was weighted towards patients with severe self-injurious behavior, which often was the reason for admission. The many “faces” of catatonia in autism spectrum disorders are seen in this sample, and the novel recognition of repetitive self-injury as an under-recognized motor symptom of catatonia is highlighted. The preliminary findings in this study open many important future vistas for ongoing research regarding catatonia in ASDs.
- 28 May 2015
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 132 (4) , 319-320
Neuroleptic malignant syndrome and delirious mania as malignant catatonia in autism: prompt relief with electroconvulsive therapy
- 28 May 2015
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 132 (4) , 319-320
Neuroleptic malignant syndrome and delirious mania as malignant catatonia in autism: prompt relief with electroconvulsive therapy